Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.71 USD | +3.47% | +6.43% | -12.51% |
May. 08 | Transcript : Arcus Biosciences, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Earnings Flash (RCUS) ARCUS BIOSCIENCES Posts Q1 Revenue $145M | MT |
Financials (USD)
Sales 2024 * | 162M | Sales 2025 * | 123M | Capitalization | 1.52B |
---|---|---|---|---|---|
Net income 2024 * | -311M | Net income 2025 * | -396M | EV / Sales 2024 * | 5.3 x |
Net cash position 2024 * | 663M | Net cash position 2025 * | 415M | EV / Sales 2025 * | 8.99 x |
P/E ratio 2024 * |
-4.8
x | P/E ratio 2025 * |
-3.83
x | Employees | 577 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.18% |
Latest transcript on Arcus Biosciences, Inc.
1 day | +3.47% | ||
1 week | +6.43% | ||
Current month | +9.72% | ||
1 month | -0.12% | ||
3 months | +5.69% | ||
6 months | +23.41% | ||
Current year | -12.51% |
Managers | Title | Age | Since |
---|---|---|---|
Juan Jaen
FOU | Founder | 66 | 14-12-31 |
Terry Rosen
CEO | Chief Executive Officer | 65 | 14-12-31 |
Robert Goeltz
DFI | Director of Finance/CFO | 51 | 20-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Terry Rosen
CEO | Chief Executive Officer | 65 | 14-12-31 |
Kathryn Falberg
BRD | Director/Board Member | 63 | 17-09-17 |
Yasunori Kaneko
BRD | Director/Board Member | 69 | 15-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.88% | 11 M€ | -6.03% | - | |
0.28% | 0 M€ | -2.98% | - | |
0.12% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 16.71 | +3.47% | 966,756 |
24-05-09 | 16.15 | +5.83% | 967,544 |
24-05-08 | 15.26 | -1.93% | 505,292 |
24-05-07 | 15.56 | -2.45% | 366,197 |
24-05-06 | 15.95 | +1.59% | 302,687 |
Delayed Quote Nyse, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.51% | 1.52B | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- RCUS Stock